A new study has provided hope that previously studied SapC-DOPS could be used for treatment of brain cancer that has spread. "These results support the potential of SapC-DOPS for the diagnosis and therapy of primary and metastatic brain tumors which is critically needed to increase survival rates of patients with this illness,” one researcher said.